Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects
Transplant Immunology · 2026
DOI: 10.1016/j.trim.2026.102446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Immunology, 2026. Verfasst von Giulia Tirloni und 13 weiteren Autor:innen. Beteiligte Einrichtung: ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy. Electronic address: giulia.tirloni@ospedaleniguarda.it. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Cytomegalovirus, HLA Antigens, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
HLA Evolutionary Divergence (HED) measures the structural differences between alleles at a single locus reflecting the immunopeptidome. While high HED is associated with better T-cell responses against pathogens and tumors, its role in determining initial susceptibility to Cytomegalovirus (CMV) remains unexplored. We analyzed HLA typing and CMV IgG data from 526 adult HSCT patients and their donors at the ASST Grande Ospedale Metropolitano Niguarda (1987-2023). HED was calculated using the Grantham distance for HLA-A, B, C, -DRB1, -DQB1, and -DPB1. We compared HED scores between CMV-seropositive (IgG+) and seronegative (IgG-) individuals using the Mann-Whitney U test to determine if HLA divergence influences initial viral susceptibility. The results showed no statistically significant differences across individual loci or grouped Class I and II HED scores, indicating no correlation between HED and CMV serological status. The lack of correlation with serostatus does not rule out HED's clinical utility. Given that HLA-specific binding to ppo5 and IEl is vital for viral control, future research should investigate if HED affects CMV reactivation post-transplant. Expanding this analysis to larger, multicenter datasets will help determine if HLA divergence serves as a viable prognostic marker for HSCT outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy. Electronic address: giulia.tirloni@ospedaleniguarda.it.
- ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
- Laboratorio HLA, Hopital Saint-Louis, APHP Parigi, France.
- IRCCS San Gerardo dei Tintori, Monza, Italy.
Zitieren
APA
Tirloni, G., Chiavetta, V., Villemonteix, J., Jorge-Cordeiro, D., Grillo, G., Cairoli, R., Di Maggio, G., Cornacchini, G., Toullec, L., Caillat-Zucman, S., Allain, V., Milano, A., Volpato, E., & Crocchiolo, R. (2026). Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102446
Vancouver
Tirloni G, Chiavetta V, Villemonteix J, Jorge-Cordeiro D, Grillo G, Cairoli R, et al. Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects. Transplant Immunology. 2026. doi:10.1016/j.trim.2026.102446
BibTeX
@article{Tirloni2026,
author = {Tirloni, Giulia and Chiavetta, Viola and Villemonteix, Juliette and Jorge-Cordeiro, Debora and Grillo, Giovanni and Cairoli, Roberto and Di Maggio, Giulia and Cornacchini, Giorgia and Toullec, Laurie and Caillat-Zucman, Sophie and Allain, Vincent and Milano, Antonio and Volpato, Elisabetta and Crocchiolo, Roberto},
title = {Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects},
journal = {Transplant Immunology},
year = {2026},
doi = {10.1016/j.trim.2026.102446}
}
EUVIMED